Close Menu

NEW YORK (GenomeWeb) – Purigen Biosystems announced today that it has completed a $26.4 million Series B financing round.

The funding round was led by Agilent Technologies, and included participation from new investor Cota Capital along with existing investors 5AM Ventures and Roche Venture Fund.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.